Immatics at the 3rd Annual CAR-T Congress EU (Jan 30-31) in London, UK

| News, USA

Immatics will attend the CAR-T Congress (Jan 30-31) in London, UK! If you’re interested in how Immatics moves forward Adoptive T-Cell Therapy research join the presentation:

 

January 30th, 2.55pm - 3.30pm

Presentation: "ACTallo®: Off-The-Shelf T-Cell Therapy Engineered Against Novel Tumor Targets"

Presenter: Yannick Bulliard (Director Translational Development)

 

We’re looking forward to interesting and exciting discussions. 

Further information on the 3rd Annual CAR-T Congress EU here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.